Isthmus Partners’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
VPM
RP
VCM
Isthmus Partners's ACLS Position: Q1 2026 in Review
Isthmus Partners reduced its Axcelis (ACLS) stake by 5.1% in Q1 2026, selling an estimated $188K and leaving 39,357 shares worth $3.66M. The position accounts for 0.38% of the portfolio, ranked #65.
Isthmus Partners first reported a position in ACLS in Q1 2024 and has held it in 9 quarters since. The position peaked at $4.73M in Q2 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- Isthmus Partners held 39,357 shares of Axcelis worth $3.66M as of Q1 2026.
- Isthmus Partners sold 2,123 Axcelis shares in Q1 2026, an estimated $188K.
- Axcelis made up 0.38% of Isthmus Partners's portfolio in Q1 2026, its #65 holding.
- Isthmus Partners first reported a position in Axcelis in Q1 2024 and has held it in 9 quarters since.
- Isthmus Partners's Axcelis position peaked at $4.73M in Q2 2024.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on Isthmus Partners's 13F filing for Q1 2026, filed 30 Apr 2026.